Analysts already are speculating dire outcomes if the price of a gallon of gas eclipses $5 this summer on account of Middle East turmoil today. Any additional strains on the supply chain system, such as increased operational costs as high as 20%, would only make matters worse.

The name of the game for tomorrow’s successful healthcare retailer is ubiquity — because it’s no longer good enough to have the better corner location or the splashiest of websites; tomorrow’s healthcare retailer will need to be able to interact with its patient whenever, however and wherever that patient happens to be at the time.

Physicians are 30% more likely to prescribe a drug that gives patients incentives to remain adherent to it than they are to prescribe a drug without such a program, according to a new survey.

Give a man a doctor’s co-pay, and he is healthy for a day. Give him a health savings account, and that man becomes so much more vested in ensuring positive health outcomes that he may be healthy for a lifetime. Because in the long run, it’s cheaper.

Weis Markets streamlined its internal connection between wellness and pharmacy earlier this year with an organizational restructure that folded the Weis Lifestyle Initiatives department, led by registered dietitian Karen Buch, into the grocer’s pharmacy division.

The news that CVS Caremark's Pharmacy Advisor program has been recognized by the Pharmacy Benefit Management Institute is yet one more illustration of how the company has positioned itself along the front lines to leverage its various points of care to improve outcomes and lower healthcare costs.

Walgreens on Monday rounded out the pharmacy purchasing team led by Jeff Berkowitz, who joined Walgreens in the fall as SVP pharmaceutical development and market access. The team reporting to Berkowitz includes Walgreen veterans Frank DeStefano, Mike Bleser and Mike Allen, as well as newcomers Jeff Foreman and Gary Gleeson.

The cardiovascular drug market will turn into a difficult conquest in the years to come as it increasingly will be dominated by generics, but that isn’t stopping drug companies from continuing to develop treatments — 299 of them, according to a recent report by the Pharmaceutical Research and Manufacturers of America — for high cholesterol, hypertension, atrial fibrillation, heart failure and other heart-related conditions.

As much as the Affordable Care Act was a tough pill to swallow for many conservatives, the flexible spending account changes may be the first piece of what many consider to be "bad medicine" to be reversed this year. Incentivizing self-care is better medicine for all constituents.

New twists on classic candy brands helped propel dollar sales in the chocolate candy segment ahead nearly 10%. An increase in prices contributed to the dollar sales gain, but a big boost came from line extensions and limited-edition flavors.

Thanks to technological innovations within mascara, the category has driven sales of eye makeup, and looking forward, mascara formulas that are infused with eyelash-enhancing treatments and packaging that offers greater customization not only will volumize lashes but also sales at retail.